Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.62% is 51% above its 1-year average of 1.74%, near the high end of its 1-year range (0.86%–2.62%).
As of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.62%.
RETURN ON EQUITY (ROE)
2.62%
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
9.65%
median of 412 covered companies
CURRENT VS SECTOR MEDIAN
-72.81%
vs the sector median at left
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$649.10M
Return on Equity (ROE)
2.62%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$651.32M
Return on Equity (ROE)
12.90%
TTM Avg
9.66%
3Y Avg
11.33%
5Y Avg
10.45%
Market Cap
$651.85M
Return on Equity (ROE)
13.35%
TTM Avg
11.47%
3Y Avg
13.92%
5Y Avg
15.35%
Market Cap
$637.82M
Return on Equity (ROE)
12.73%
TTM Avg
17.82%
3Y Avg
12.75%
5Y Avg
-231.02%
Market Cap
$635.10M
Return on Equity (ROE)
-29.00%
TTM Avg
9.63%
3Y Avg
-1180.61%
5Y Avg
-805.61%
Market Cap
$633.40M
Return on Equity (ROE)
6.96%
TTM Avg
7.56%
3Y Avg
6.50%
5Y Avg
3.41%
Market Cap
$630.67M
Return on Equity (ROE)
7.58%
TTM Avg
5.21%
3Y Avg
5.83%
5Y Avg
7.95%
Market Cap
$669.58M
Return on Equity (ROE)
25.53%
TTM Avg
20.37%
3Y Avg
16.53%
5Y Avg
16.70%
Market Cap
$672.06M
Return on Equity (ROE)
10.67%
TTM Avg
10.86%
3Y Avg
5.55%
5Y Avg
6.20%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $649.10M | 2.62% | N/A | N/A | N/A |
| ACNB Corporation (ACNB)vs › | $651.32M | 12.90% | 9.66% | 11.33% | 10.45% |
| Capital Bancorp, Inc. (CBNK)vs › | $651.85M | 13.35% | 11.47% | 13.92% | 15.35% |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $637.82M | 12.73% | 17.82% | 12.75% | -231.02% |
| American Bitcoin Corp (ABTC)vs › | $635.10M | -29.00% | 9.63% | -1180.61% | -805.61% |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $633.40M | 6.96% | 7.56% | 6.50% | 3.41% |
| Hypoport SE (HYPOF)vs › | $630.67M | 7.58% | 5.21% | 5.83% | 7.95% |
| Gladstone Investment Corporation (GAINI)vs › | $669.58M | 25.53% | 20.37% | 16.53% | 16.70% |
| Donegal Group Inc. (DGICA)vs › | $672.06M | 10.67% | 10.86% | 5.55% | 6.20% |
| Coastal Financial Corporation (CCB)vs › | $624.44M | -0.83% | 9.94% | 12.92% | 12.65% |
ROE
2.6%
ROA
2.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.62% |
| 2026-03-31 | 1.75% |
| 2025-12-31 | 0.86% |
